Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lovise Maehle

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Breast (Edinburgh, Scotland)|February 24, 2007
Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective seriesAnne I Hagen, Kjell Arne Kvistad, Lovise Maehle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
Germ-line mutations in mismatch repair genes associated with prostate cancerEli Marie Grindedal, Pål Møller, Ros Eeles, et al.
Genes, Chromosomes & Cancer|November 21, 2007
Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomasPer Helsing, Dag Andre Nymoen, Sarah Ariansen, et al.
International Journal of Cancer|May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusPal Moller, D Gareth Evans, Marta M Reis, et al.
Plos One|August 30, 2008
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancerRanjan Chrisanthar, Stian Knappskog, Erik Løkkevik, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
The Prostate|November 29, 2017
Genetic factors influencing prostate cancer risk in Norwegian menHaitao Chen, Charles M Ewing, Sigun Zheng, et al.
Journal of Medical Genetics|July 1, 2010
Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriersWenche Sjursen, Bjørn Ivar Haukanes, Eli Marie Grindedal, et al.
Journal of Medical Genetics|July 29, 2009
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindredsEli Marie Grindedal, Laura Renkonen-Sinisalo, Hans Vasen, et al.
International Journal of Cancer|August 30, 2018
ANO7 is associated with aggressive prostate cancerElina Kaikkonen, Tommi Rantapero, Qin Zhang, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Breast (Edinburgh, Scotland)|February 24, 2007
Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective seriesAnne I Hagen, Kjell Arne Kvistad, Lovise Maehle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 3, 2009
Germ-line mutations in mismatch repair genes associated with prostate cancerEli Marie Grindedal, Pål Møller, Ros Eeles, et al.
Genes, Chromosomes & Cancer|November 21, 2007
Population-based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomasPer Helsing, Dag Andre Nymoen, Sarah Ariansen, et al.
International Journal of Cancer|May 2, 2007
Surveillance for familial breast cancer: Differences in outcome according to BRCA mutation statusPal Moller, D Gareth Evans, Marta M Reis, et al.
Plos One|August 30, 2008
CHEK2 mutations affecting kinase activity together with mutations in TP53 indicate a functional pathway associated with resistance to epirubicin in primary breast cancerRanjan Chrisanthar, Stian Knappskog, Erik Løkkevik, et al.
International Journal of Cancer|September 19, 2002
Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomyPål Møller, Ake Borg, D Gareth Evans, et al.
The Prostate|November 29, 2017
Genetic factors influencing prostate cancer risk in Norwegian menHaitao Chen, Charles M Ewing, Sigun Zheng, et al.
Journal of Medical Genetics|July 1, 2010
Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriersWenche Sjursen, Bjørn Ivar Haukanes, Eli Marie Grindedal, et al.
Journal of Medical Genetics|July 29, 2009
Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindredsEli Marie Grindedal, Laura Renkonen-Sinisalo, Hans Vasen, et al.
International Journal of Cancer|August 30, 2018
ANO7 is associated with aggressive prostate cancerElina Kaikkonen, Tommi Rantapero, Qin Zhang, et al.
Pageof 5